Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FASENRA Subcutaneous Injection 30 mg Syringe Specific Clinical Experience Investigation for Long-term Use

NCT03588546 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03588546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03588546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FASENRA Subcutaneous Injection 30 mg Syringe Specific Clinical Experience Investigation for Long-term Use
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2018
Completion date
September 10, 2024
Enrollment
653 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

asthma